Archive for 2010

Drug inventor report profiles individuals, US states, and countries leading pharmaceutical innovation

A new report from DrugPatentWatch.com profiles the leading researchers, US states, and countries responsible for drugs approved over the past ten years. The report features: Top Inventors Which inventors were granted the most patents? Patents per Inventor The patents awarded to each inventor Approved Drugs per Inventor The approved drugs protected by each inventor’s patents […]


Drug Patent Expirations in August 2010

Drug Patent Expirations in August 2010 Tradename Applicant Generic Name Patent Number Patent Expiration ATRIPLA Gilead efavirenz; emtricitabine; tenofovir disoproxil fumarate 7,402,588*PED Aug 1, 2010 TRUVADA Gilead emtricitabine; tenofovir disoproxil fumarate 7,402,588*PED Aug 1, 2010 EMTRIVA Gilead emtricitabine 7,402,588*PED Aug 1, 2010 GENESA Gensia Automedics arbutamine hydrochloride 5,234,404 Aug 10, 2010 PREVPAC Takeda Pharms Na […]


Synthetic Biology: What's the Agenda?

The Center for Policy on Emerging Technologies, where I am on the board of directors, is hosting an Emerging Technologies Roundtable: August 13, 2010 – “Synthetic Biology: What’s the Agenda?” Synthetic biology has hit the headlines yet again. The J. Craig Venter Institute’s recent dramatic announcement led to a replay of President Clinton’s urgent request […]


Journal of Commercial Biotechnology — July 2010 issue now available

The July 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 16, Issue 3 Editorial Increasing clarity PDF Yali Friedman Commentary Personalized medicine and oncology: A commentary and key questions PDF Robert Freeman Articles Market access – An essential investment […]


Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business

Now available, a new textbook from Logos Press: Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business Available from Amazon.com and bookstores everywhere. Mark J. Ahn, Michael A. Alvarez, Arlen D. Meyers, Anne S. York, editors Foreword by G. Steven Burrill First Edition, July 2010 Perfect Bound, 416 pages, […]


Biotech U — Free online biotechnology course

I’ve decided to open up Biotech U and make the comprehensive biotechnology industry overview course free for the month of July. The course is derived from my textbook, Building Biotechnology, and covers the following topics: Biotechnology Industry Introduction The Development of Biotechnology Preface: The Science of Biotechnology Introduction to Molecular Biology Drug Development Tools and […]


Drug Patent Expirations in July 2010

Drug Patent Expirations in July 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration PROAIR HFA Teva Global albuterol sulfate 5,695,743 Jul 6, 2010 XOPENEX HFA Sepracor levalbuterol tartrate 5,225,183 Jul 6, 2010 PROVENTIL-HFA 3m albuterol sulfate 5,439,670 Jul 6, 2010 XOPENEX HFA Sepracor levalbuterol tartrate 5,695,743 Jul […]